Section Arrow
ELUT.NASDAQ
- Elutia
(Financial Status)
Quotes are at least 15-min delayed:2026/01/24 00:54 EST
Regular Hours
Last
 0.95
-0.06 (-5.94%)
Day High 
1.08 
Prev. Close
1.01 
1-M High
1.05 
Volume 
402.77K 
Bid
0.9105
Ask
1.05
Day Low
0.92 
Open
0.995 
1-M Low
0.5175 
Market Cap 
43.13M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.82 
20-SMA 0.71 
50-SMA 0.68 
52-W High 3.46 
52-W Low 0.5 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.87/-1.71
Enterprise Value
66.15M
Balance Sheet
Book Value Per Share
-1.03
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
24.38M
Operating Revenue Per Share
1.13
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MOVEMovano Inc16.74+9.77+140.17%-- 
ABTAbbott Laboratories107.42-1.19-1.10%13.69PE
BSXBoston Scientific Corp92.51+1.22+1.34%48.82PE
MDTMedtronic plc100.88-0.46-0.45%27.46PE
PFSAProfusa Inc0.114-0.0014-1.21%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patientsreceiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.